Johnson & Johnson Innovation announces extension of innovation partnering office at Monash University in collaboration with Victorian State…

You are here:

14 July 2021

-Victorian State Government extends financing ofJJIPO@Monashfor an additional two years

-Extension will further boost Victorian hub for researchers and early-stage companies to connect with industry experts and deliver novel healthcare solutions

MELBOURNE, Australia,July 15, 2021/PRNewswire/ -- Johnson & Johnson Innovation announced today the extension of the Johnson & Johnson Innovation Partnering Office at Monash University'sClayton CampusinMelbourne(JJIPO@Monash) in collaboration with the Victorian State Government.

This joint initiative between Johnson & Johnson Innovation, the Victorian Government and Monash University will be extended for approximately two years throughJune 30, 2023. The agreement will allowJJIPO@Monashto continue connecting with the Victorian innovation ecosystem, nurturing and accelerating innovative research, new product development and commercialisation for a global market, as well as boost local job creation inVictoria.

"Our collaboration with Monash University represents Johnson & Johnson Innovation's ongoing commitment to foster diverse healthcare ecosystems acrossAustralia. This extension will further help connect life-science innovators inVictoriato accelerate their healthcare solutions across the globe," saidStacy Feld, Regional Head, Johnson & Johnson Innovation LLC,West North America,Australia&New Zealand.

Since 2012, Johnson & Johnson Innovation has played an active role in establishing connections with key stakeholders in theAustralialife-science ecosystem, including academia, government and venture capitalists, to enable public-private collaboration and support early-stage entrepreneurs and academic researchers.JJIPO@Monashwas originally launched in 2018 to provide crucial support to researchers and companies in the Victorian life-science sector as part of the Government's commitment to the medical technologies and pharmaceuticals sector one of eight priority growth sectors. The public-private partnership between Johnson & Johnson Innovation, Monash University and the Victorian Government is one of only three such offices located across the world.

"Victoriahas one of the world's largest life science clusters composed of medical technologies (medtech), biotechnologies and pharmaceutical industries. It's home to a vibrant commercial sector, key R&D infrastructure and advanced manufacturing expertise making it a highly sought-after destination by global healthcare companies," saidJaala Pulford, Minister for Innovation, Parliament ofVictoria. "This is why we are delighted to extend our joint agreement with Johnson & Johnson Innovation to maintain the partnering office at Monash."

"This contract extension demonstrates the valuable work that is taking place atJJIPO@Monash," saidKathy Connell, Senior Director, Early Innovation Partnering, Australia&New Zealand, Janssen-Cilag Pty Ltd. "Several high impact Victorian healthcare collaborations have been signed since our launch, including those novel medical technologies and treatments for neurodegenerative and autoimmune conditions, and solutions for significant unmet needs in global public health including maternal mortality and infectious diseases."

Since its inception in 2018,JJIPO@Monashhas provided a platform for major life-science collaboration inVictoriato strengthen the healthcare ecosystem and enable future impact, including:

Monash University Deputy Vice-Chancellor & Senior Vice-President (Enterprise & Governance), ProfessorKen Sloan, said the contract extension will further raiseVictoria'sreputation as a global innovation hot spot.

"This partnership is helping to bridge the gap between academic research and industry application by driving cross-industry conversations, leading to project innovations and investment. I am excited to see what we will achieve in this new phase," said Professor Sloan.

JJIPO@Monashprovides mentoring, training and networking with emerging healthcare companies and academic researchers at no financial cost to life science stakeholders acrossVictoriato help nurture the next generation of innovators. Commercialisation training, mentoring and networking support is provided to accelerate translational life science research along the path to commercialisation and to connect Victorian innovators with stakeholders from Johnson & Johnson Innovation's vast global networks. These activities are part of Johnson & Johnson Innovation's ongoing commitment to strengthenVictoria'shealthcare innovation ecosystem and to accelerating the opportunity for locally developed technologies to receive investment dollars, to reach patients faster, and to realize a fair return on investment.

The Victorian Government's renewed financial support will continue to strengthen the partnership. The program of activities offered throughJJIPO@Monashwill ensure Johnson & Johnson Innovation has an ongoing and active presence inVictoriaand will continue to build a commercially viable bio-medtech innovation network, create sector employment and ultimately deliver Victorian-originated healthcare solutions to people inAustraliaand around the world.

Originally posted here:

Johnson & Johnson Innovation announces extension of innovation partnering office at Monash University in collaboration with Victorian State...